Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Cleveland Clinic Researcher Receives $3.2 Million NIH Grant To Develop Bio-Artificial Kidney

Abstract:
Shuvo Roy, Ph.D., of Cleveland Clinic's Lerner Research Institute to develop alternative to dialysis using silicon nanotechnology.

Cleveland Clinic Researcher Receives $3.2 Million NIH Grant To Develop Bio-Artificial Kidney

Cleveland, OH | Posted on October 5th, 2007

The National Institute of Biomedical Imaging and Bioengineering awarded Shuvo Roy, Ph.D., a $3.2 million, three-year grant today to develop a bio-artificial kidney that can be used instead of dialysis.

Dr. Roy and his team are using MEMS (microelectromechanical systems) technology to create an implantable, self-regulating bio-artificial kidney that will filter toxins and absorb necessary salts and water like human kidneys. The team includes physicians and engineers from the Lerner Research Institute‚s Department of Biomedical Engineering and Cleveland Clinic's Department of Nephrology.

"We are bringing together the necessary multidisciplinary expertise to focus on critical technical hurdles to develop an implantable hemofilter and cell bioreactor, which are the integral components of the bio-artificial kidney," Dr. Roy said.

Martin Schreiber, M.D., Chairman of the Cleveland Clinic's Department of Nephrology and Hypertension, said the grant will help further one of Cleveland Clinic's key missions.

"This award fulfills the first step in developing innovative technology platforms which offer new hope for extending survival in patients with kidney failure," he said. "Innovation is one of the hallmarks of the Cleveland Clinic and this project continues that tradition."

Paul E. DiCorleto, Ph.D., Chairman of Lerner Research Institute added, "A program like this is an excellent example of our continual efforts to find ways to translate laboratory-based research into novel therapies and treatments that improve patient care."

More than 50 million dialysis procedures are performed annually in the U.S, according to data from the United States Renal Data System. The treatment of choice, kidney transplant, is severely limited by scarcity of donor organs, such that only 25 percent of patients on the waiting list for a transplant survive long enough to receive a kidney.

The implantable bioartificial kidney Dr. Roy and his team are developing could substitute for kidney transplantation, thereby giving hope, independence, and mobility to more than 300,000 patients presently tethered to thrice-weekly in-center dialysis. Dr. Roy‚s grant is one of four awarded by NIBIB‚s Quantum Grants program. The overall goal of the NIBIB Quantum Grants program is to make a profound (quantum level) advance in healthcare by funding research on targeted projects that will develop new technologies and modalities for the diagnosis, treatment, or prevention of disease.

####

For more information, please click here

Contacts:
Scott Heasley
Phone: 216.444.8853

Copyright © Cleveland Clinic

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

MEMS

Carbyne morphs when stretched: Rice University calculations show carbon-atom chain would go metal to semiconductor July 21st, 2014

Leti to Present Technological Platforms Targeting Industry’s Needs for the Future at Semicon West Workshop: Presentation at STS Session to Focus on Leti Advanced Lithography Programs for 1x Nodes and on Silicon Photonics at TechXPot June 25th, 2014

Mirrorcle Technologies Opens New Company Headquarters May 27th, 2014

Ziptronix and EV Group Demonstrate Submicron Accuracies for Wafer-to-Wafer Hybrid Bonding: Enables Fine-Pitch Connections for 3D Applications, Including Image Sensors, Memory and 3D SoCs May 27th, 2014

Nanomedicine

PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014

The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment: Targeted therapy for hepatocellular carcinoma using nanotechnology August 27th, 2014

Introducing the multi-tasking nanoparticle: Versatile particles offer a wide variety of diagnostic and therapeutic applications August 26th, 2014

Symphony of nanoplasmonic and optical resonators leads to magnificent laser-like light emission August 26th, 2014

Announcements

Nanodiamonds Are Forever: A UCSB professor’s research examines 13,000-year-old nanodiamonds from multiple locations across three continents August 27th, 2014

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014

Nanotech Security Corp. to Acquire Fortress Optical Features Ltd., a Leading Producer of Banknote Security Features August 27th, 2014

Malvern specialists to deliver inaugural short course on polymer characterization at Interplas 2014 August 27th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Rice physicist emerges as leader in quantum materials research: Nevidomskyy wins both NSF CAREER Award and Cottrell Scholar Award August 20th, 2014

Oxford Instruments Asylum Research Receives the 2014 Microscopy Today Innovation Award for blueDrive Photothermal Excitation August 18th, 2014

AQUANOVA receives Technology Leadership Award 2014 FROST & SULLIVAN honors NovaSOL® Technology again August 12th, 2014

Focal blood-brain-barrier disruption with high-frequency pulsed electric fields August 12th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE